SEC Form 4 · accession 0001055726-16-000037
INOVIO PHARMACEUTICALS, INC. · INO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Morton Collins
Director
Period of report
Apr 15, 2016
Accepted (ET)
Apr 18, 2016 · 2:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001055726
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 15, 2016 | P | 6,200 | $9.446 | A | 28,700 | I | By Morton Collins IRA account |
| Common Stock | Apr 15, 2016 | P | 2,000 | $9.4897 | A | 6,450 | I | By Spouse |
| Common StockF1 | Apr 15, 2016 | P | 4,200 | $9.4571 | A | 6,650 | I | By Spouse IRA account |
| Common Stock | Apr 15, 2016 | P | 28,000 | $9.57 | A | 64,750 | I | By Collins Children's Trust |
| Common Stock | Apr 15, 2016 | P | 28,000 | $9.4893 | A | 64,750 | I | By Collin Grandchildren's Trust |
| Common StockF1 | holding | — | — | — | 127,291 | D | ||
| Common StockF1 | holding | — | — | — | 4,500 | I | The Collins Family Foundation Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1We are showing a change in form of ownership; however there has been no change in beneficial ownership besides the transactions reported.